These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 22211319

  • 1. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics.
    Abdelouhab K, Rafa H, Toumi R, Bouaziz S, Medjeber O, Touil-Boukoffa C.
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):590-7. PubMed ID: 22211319
    [Abstract] [Full Text] [Related]

  • 2. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.
    Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, Touil-Boukoffa C.
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):403-9. PubMed ID: 23638770
    [Abstract] [Full Text] [Related]

  • 3. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.
    Komiyama Y, Andoh A, Fujiwara D, Ohmae H, Araki Y, Fujiyama Y, Mitsuyama K, Kanauchi O.
    Scand J Gastroenterol; 2011 Jan; 46(1):40-52. PubMed ID: 20735154
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
    Kwon KH, Murakami A, Hayashi R, Ohigashi H.
    Biochem Biophys Res Commun; 2005 Nov 18; 337(2):647-54. PubMed ID: 16202978
    [Abstract] [Full Text] [Related]

  • 5. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH, Murakami A, Tanaka T, Ohigashi H.
    Biochem Pharmacol; 2005 Feb 01; 69(3):395-406. PubMed ID: 15652231
    [Abstract] [Full Text] [Related]

  • 6. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P, Dray X, Sokol H, Marteau P.
    Mol Nutr Food Res; 2008 Aug 01; 52(8):906-12. PubMed ID: 18384087
    [Abstract] [Full Text] [Related]

  • 7. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H, Okazaki K, Tabata Y, Chiba T.
    J Gastroenterol; 2003 Mar 01; 38 Suppl 15():59-62. PubMed ID: 12698874
    [Abstract] [Full Text] [Related]

  • 8. Probiotic bacteria lactobacillus and bifidobacterium attenuate inflammation in dextran sulfate sodium-induced experimental colitis in mice.
    Toumi R, Soufli I, Rafa H, Belkhelfa M, Biad A, Touil-Boukoffa C.
    Int J Immunopathol Pharmacol; 2014 Mar 01; 27(4):615-27. PubMed ID: 25572742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C, Whelan K, Lindsay JO.
    Proc Nutr Soc; 2007 Aug 01; 66(3):307-15. PubMed ID: 17637082
    [Abstract] [Full Text] [Related]

  • 12. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
    Nishitani Y, Tanoue T, Yamada K, Ishida T, Yoshida M, Azuma T, Mizuno M.
    Int Immunopharmacol; 2009 Nov 01; 9(12):1444-51. PubMed ID: 19733697
    [Abstract] [Full Text] [Related]

  • 13. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
    Verbeke KA, Boesmans L, Boets E.
    Proc Nutr Soc; 2014 Nov 01; 73(4):490-7. PubMed ID: 24969143
    [Abstract] [Full Text] [Related]

  • 14. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
    Lee HS, Han SY, Bae EA, Huh CS, Ahn YT, Lee JH, Kim DH.
    Int Immunopharmacol; 2008 Apr 01; 8(4):574-80. PubMed ID: 18328449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
    Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T.
    Int J Mol Med; 2006 Jun 01; 17(6):997-1004. PubMed ID: 16685407
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
    Mikami S, Nakase H, Yamamoto S, Takeda Y, Yoshino T, Kasahara K, Ueno S, Uza N, Oishi S, Fujii N, Nagasawa T, Chiba T.
    J Pharmacol Exp Ther; 2008 Nov 01; 327(2):383-92. PubMed ID: 18716065
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Suqingwan watered pill reduces colon injury induced by experimental colitis.
    Han N, Li G, Kang R, Li Q, Liu Z, Jiang S, Yin J.
    J Ethnopharmacol; 2011 Jun 14; 136(1):144-8. PubMed ID: 21527334
    [Abstract] [Full Text] [Related]

  • 20. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R, Totsuka T, Takeda K, Akira S, Watanabe M.
    J Gastroenterol; 2005 Jan 14; 40(1):16-23. PubMed ID: 15692785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.